Table 2.
Characteristics | Disease recurrence | Overall mortality | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Univariate | Multivariate | Univariate | Multivariate | |||||||||
Hazard ratio | 95% CI | p value | Hazard ratio | 95% CI | p value | Hazard ratio | 95% CI | p value | Hazard ratio | 95% CI | p value | |
Gender (male vs. female) | 0.979 | 0.522–1.835 | 0.947 | 0.562 | 0.263–1.201 | 0.137 | ||||||
Age ≥ 60 vs. < 60 | 1.366 | 0.791–2.358 | 0.263 | 2.948 | 1.344–6.468 | 0.007 | 2.947 | 1.230–7.058 | 0.015 | |||
pT Stage (pT3,4 vs. pT1,2) | 3.273 | 1.850–5.792 | < 0.001 | 4.547 | 2.108–9.809 | < 0.001 | ||||||
Grade (3,4 vs. 1,2) | 4.050 | 2.309–7.103 | < 0.001 | 2.299 | 1.159–4.559 | 0.017 | 5.553 | 2.619–11.773 | < 0.001 | |||
Venous invasion (yes vs. no) | 2.936 | 1.679–5.135 | < 0.001 | 2.192 | 1.129–4.259 | 0.021 | 4.717 | 2.149–10.353 | < 0.001 | 3.086 | 1.092–8.715 | 0.033 |
CD8+ T-cell heterogeneity | < 0.001 | 0.004 | 0.001 | |||||||||
CD8low | Reference | Reference | Reference | |||||||||
CD8highCD39low | 0.396 | 0.052–3.052 | 0.374 | 0.217 | 0.028–1.712 | 0.147 | 0.000 | 0.000 | 0.976 | |||
CD8highCD39highPD-1low | 3.002 | 1.521–5.922 | 0.002 | 2.546 | 1.274–5.088 | 0.008 | 2.586 | 1.001–6.682 | 0.050 | |||
CD8highCD39highPD-1high | 7.931 | 3.362–18.705 | < 0.001 | 3.262 | 1.260–8.446 | 0.015 | 8.063 | 2.836–22.925 | < 0.001 |